Founded in 2019 and based in Philadelphia, BioAlert Technologies's mission is develop methodologies to detecting infection in real-time. We are a developmental stage medical device company dedicated to the design and development of continuous infection monitoring (CIM) systems for diabetic foot ulcer patients. BioAlert Technologies enables healthcare providers to make diagnosis and treatment decisions based off of reliable data metrics.
| Website | http://www.bioalerttech.com |
| Employees | 6 (0 on RocketReach) |
| Founded | 2019 |
| Address | 220 S 33rd St, Philadelphia, Pennsylvania, US |
| Industry | Medical Equipment Manufacturing, Health Care, Health Diagnostics, Medical Device |
| Keywords | Medical Device Development, Infectious Disease Diagnostics, Infection Control, Point-Of-Care Diagnostics, Biosensors, Rapid Diagnostic Tests, Biomedical Engineering, Diagnostic Devices, Patient Monitoring, Disease Surveillance, Clinical Diagnostics, In-Vitro Diagnostics, Healthcare Technology, Diagnostic Tools, Medical Technology, Antimicrobial Resistance |
| Competitors | Roche, Medtronic, Abbott, Dexcom, VUE Cinemas, Senseonics, Incorporated, InTouch Health, Zebra Medical Vision Ltd, Nemaura Medical Inc, Wearable X +40 more (view full list) |
Looking for a particular BioAlert Technologies employee's phone or email?
BioAlert Technologies is based in Philadelphia, Pennsylvania.